投稿信息
投稿信息
投稿命中率
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量76.87% (2022年為57.14%)
自引率
4.0 %
年文章數(shù)
977
NCBI查詢
期刊簡介
稿件收錄要求
稿件收錄要求
Apoptosis is an international peer-reviewed journal published bimonthly. The Journal is devoted to the rapid publication of innovative basic and clinically-oriented investigations into programmed cell death. It aims to stimulate both research on the basis of mechanisms of apoptosis and on its role in various human disease processes including: cancer autoimmune disease viral infection AIDS cardiovascular disease neurodegenerative disorders osteoporosis and ageing. The Editor-In-Chief recognises the need to encourage the development of clinical therapies against apoptosis-related diseases.
Apoptosis is a peer-reviewed journal devoted to basic and clinically-oriented investigations into programmed cell death.
- Stimulates research on the basis of mechanisms of apoptosis and its role in various human disease processes.
- Investigates links to cancer, autoimmune disease, viral infection, AIDS, cardiovascular disease, neurodegenerative disorders, osteoporosis and ageing.
- Encourages development of clinical therapies against apoptosis-related diseases.
- 90% of authors who participated in a survey reported they would likely publish in the journal again.
?
- Editor-in-Chief
-
- Arjan W. Griffioen,?
- Patrycja Nowak-Sliwinska
- Impact factor
- 7.2 (2022)
- 5 year impact factor
- 5.9 (2022)
- Submission to first decision (median)
- 8 days
- Downloads
- 320,711 (2022)
常用鏈接
期刊論壇
|
中國SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
